Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
- Precision Medicine Further Explored in Metastatic CRC on December 16, 2018 at 8:14 pm
John L. Marshall, MD: We are now doing molecular profiling routinely in colon cancer, but, remember, that’s a small subset. Like in lung cancer, there have been new discoveries of fairly rare mutation... […]
- Precision Medicine in Differentiated Thyroid Cancer on December 14, 2018 at 7:41 am
Eric J. Sherman, MD: The nice thing about thyroid cancer, especially papillary thyroid cancer, is that targetable mutations exist. Right now, everyone knows about BRAF. It’s the most common mutation, ... […]
- This is why doctors consider precision of medicine to be the future of health care on December 14, 2018 at 6:29 am
This is why doctors consider precision of medicine to be the future of health care For decades, the Clinic for Special Children has been practicing a type of patient-specific medicine that health syst... […]
- At the Nemours Kinder Clinic, doctors take a new approach with precision medicine on December 14, 2018 at 6:14 am
At the Nemours Kinder Clinic, doctors take a new approach with precision medicine Nemours hopes the Kinder Clinic will help create a blueprint for a "perfect medical home" that offers precision medici... […]
- Mount Sinai, Sanofi Partner on Precision Medicine for Asthma on December 13, 2018 at 6:32 am
December 13, 2018 - Mount Sinai Health System has launched a five-year, multisite study designed to advance precision medicine therapies for asthma patients. The collaborative effort, which includes S... […]
- Lack of regional research into precision medicine may hinder targeted therapies for cancers in the UAE on December 11, 2018 at 11:51 pm
UAE Vision 2021 aims to reduce cancer-related deaths, which WHO estimated to be 25.6 deaths per 100,000 population in the UAE in 2017 Barriers to providing precision medicine in the Arab world to be d... […]
- Insilico Medicine to showcase its AI Engine for Future Drug Discovery at the 2018 Future Tech Forum on December 10, 2018 at 9:52 am
IMAGE: Artur Kadurin, Chief AI Officer and CEO of Insilico Taiwan presents "AI in Drug Discovery Creates the Best Era of Precision Medicine " at the 2018 Future Tech Forum. view more Monday, December ... […]
- Precision Medicine Could Have a Major Impact on Healthcare Outcomes and Costs on December 7, 2018 at 7:40 am
The transformation of health care continues at a rapid pace, bringing opportunities and challenges for health care providers to deliver improved clinical outcomes at lower costs. Despite the tidal ... […]
- FDA Recognizes Genomic Database to Advance Precision Medicine on December 7, 2018 at 6:36 am
December 07, 2018 - The FDA has formally recognized a public database containing genomic information, a significant step forward in driving the development of precision medicine and novel diagnostic t... […]
- Expanding Precision Medicine on December 6, 2018 at 9:57 pm
Health care providers around the globe are facing a one-two punch of increasing financial pressure and expanding medical challenges due to a wide variety of factors, including growing, aging ... […]
via Google News and Bing News